Hydroxycarbamide
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Hydroxycarbamide, covering 2016-11-28 to 2024-11-18. Get the full timeline:
Most recent: Clinical Trial Update: MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera [Phase 3]